Sensitization of ON-bipolar cells with ambient light activatable multi-characteristic opsin rescues vision in mice

• Published in: Gene therapy Vol. 28; no. 3-4; pp. 162 - 176
• Main Authors: Batabyal, Subrata, Gajjeraman, Sivakumar, Pradhan, Sanjay, Bhattacharya, Sulagna, Wright, Weldon, Mohanty, Samarendra
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01-04-2021; Nature Publishing Group
• Subjects: 13/109; 14/19; 38/77; 631/378/2613; 631/61/201; 9/74; Acuity; Biomedical and Life Sciences; Biomedicine; Bipolar cells; Care and treatment; Cell Biology; Cytokines; Degenerative diseases; Gene Expression; Gene Therapy; Genetic aspects; Genetics; Health aspects; Human Genetics; Immunohistochemistry; Inflammation; Information processing; Methods; Nanotechnology; Opsins; Optics; Photoreceptors; Photosensitivity; Phototherapy; Retina; Retinal bipolar cells; Retinal degeneration; Vitreous humor; United States
• ISSN: 0969-7128; 1476-5462
• DOI: 10.1038/s41434-020-00200-2

Gene therapy-based treatment such as optogenetics offers a potentially powerful way to bypass damaged photoreceptors in retinal degenerative diseases and use the remaining retinal cells for functionalization to achieve photosensitivity. However, current approaches of optogenetic treatment rely on opsins that require high intensity light for activation thus adding to the challenge for use as part of a wearable device. Here, we report AAV2 assisted delivery of highly photosensitive multi-characteristic opsin (MCO1) into ON-bipolar cells of mice with retinal degeneration to allow activation by ambient light. Rigorous characterization of delivery efficacy by different doses of AAV2 carrying MCO1 (vMCO1) into targeted cells showed durable expression over 6 months after delivery as measured by reporter expression. The enduring MCO1 expression was correlated with the significantly improved behavioral outcome, that was longitudinally measured by visual water-maze and optomotor assays. The pro/anti-inflammatory cytokine levels in plasma and vitreous humor of the vMCO1-injected group did not change significantly from baseline or control group. Furthermore, biodistribution studies at various time points after injection in animal groups injected with different doses of vMCO1 showed non-detectable vector copies in non-targeted tissues. Immunohistochemistry of vMCO1 transfected retinal tissues showed bipolar specific expression of MCO1 and the absence of immune/inflammatory response. Furthermore, ocular imaging using SD-OCT showed no change in the structural architecture of vMCO1-injected eyes. Induction of ambient light responsiveness to remaining healthy bipolar cells in subjects with retinal degeneration will allow the retinal circuitry to gain visual acuity without requiring an active stimulation device.